New Schizophrenia Treatments Address Unmet Clinical Needs.
We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
Chris
C
Fellner